Guo et al. reported that emodin can enhance the antitumor effect of gemcitabine (the gold standard chemotherapy drug for PC) by inhibiting MDR1/P glycoprotein, MRP expression, and the IKKβ/NF-κB signaling pathway 162. The gene discussed is ABCB1; the disease is pachyonychia congenita.